WO2001085027A3 - Drug deliver catheter device with active electrode - Google Patents
Drug deliver catheter device with active electrode Download PDFInfo
- Publication number
- WO2001085027A3 WO2001085027A3 PCT/US2001/014524 US0114524W WO0185027A3 WO 2001085027 A3 WO2001085027 A3 WO 2001085027A3 US 0114524 W US0114524 W US 0114524W WO 0185027 A3 WO0185027 A3 WO 0185027A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- drug delivery
- drug
- imaging
- delivery
- active electrode
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
- G01R33/285—Invasive instruments, e.g. catheters or biopsy needles, specially adapted for tracking, guiding or visualization by NMR
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
- A61M2025/0166—Sensors, electrodes or the like for guiding the catheter to a target zone, e.g. image guided or magnetically guided
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/06—Head
- A61M2210/0693—Brain, cerebrum
Abstract
The invention is an apparatus and method for treatments and targeted drug delivery into a living patient, particularly but not exclusively using magnetic resonance (MR) imaging. The apparatus is useful in delivery to all types of living tissue and uses MR Imaging to track the location of drug delivery and estimating the rate of drug delivery. An MR-visible drug delivery device (38) positioned at a target site (e.g., intracranial delivery) delivers a diagnostic or therapeutic drug solution into the tissue (e.g., the brain). The spatial distribution kinetics of the injected or infused drug agent are monitored quantitatively and non-invasively using water proton directional diffusion MR imaging to establish the efficacy of drug delivery at a targeted location.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01931071A EP1280456A2 (en) | 2000-05-08 | 2001-05-04 | Drug deliver catheter device with active electrode |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/566,798 | 2000-05-08 | ||
US09/566,798 US7505807B1 (en) | 1997-05-15 | 2000-05-08 | Magnetic resonance apparatus for use with active electrode and drug deliver catheter |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001085027A2 WO2001085027A2 (en) | 2001-11-15 |
WO2001085027A3 true WO2001085027A3 (en) | 2002-04-25 |
Family
ID=24264414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/014524 WO2001085027A2 (en) | 2000-05-08 | 2001-05-04 | Drug deliver catheter device with active electrode |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1280456A2 (en) |
WO (1) | WO2001085027A2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9008761B2 (en) | 2010-02-01 | 2015-04-14 | Proteus Digital Health, Inc. | Two-wrist data gathering system |
US9014779B2 (en) | 2010-02-01 | 2015-04-21 | Proteus Digital Health, Inc. | Data gathering system |
US9125979B2 (en) | 2007-10-25 | 2015-09-08 | Proteus Digital Health, Inc. | Fluid transfer port information system |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1788498A1 (en) * | 2005-11-21 | 2007-05-23 | BrainLAB AG | Apparatus for infusing substances |
JP5241714B2 (en) | 2006-07-07 | 2013-07-17 | プロテウス デジタル ヘルス, インコーポレイテッド | Smart parenteral delivery system |
EP2198317A2 (en) * | 2007-09-24 | 2010-06-23 | Boston Scientific Limited | Mri phase visualization of interventional devices |
US9731122B2 (en) | 2013-04-29 | 2017-08-15 | Rainbow Medical Ltd. | Electroosmotic tissue treatment |
US9616221B2 (en) | 2015-07-08 | 2017-04-11 | Rainbow Medical Ltd. | Electrical treatment of Alzheimer's disease |
US9724515B2 (en) | 2015-10-29 | 2017-08-08 | Rainbow Medical Ltd. | Electrical substance clearance from the brain for treatment of Alzheimer's disease |
US10898716B2 (en) | 2015-10-29 | 2021-01-26 | Rainbow Medical Ltd. | Electrical substance clearance from the brain |
US10518085B2 (en) | 2015-12-29 | 2019-12-31 | Rainbow Medical Ltd. | Disc therapy |
US9770591B2 (en) | 2015-12-29 | 2017-09-26 | Rainbow Medical Ltd. | Disc therapy |
US9950156B2 (en) | 2016-09-13 | 2018-04-24 | Rainbow Medical Ltd. | Disc therapy |
US11484706B2 (en) | 2015-12-29 | 2022-11-01 | Discure Technologies Ltd | Disc therapy |
US10569086B2 (en) | 2017-01-11 | 2020-02-25 | Rainbow Medical Ltd. | Electrical microglial cell activation |
US10758722B2 (en) | 2017-05-03 | 2020-09-01 | Rainbow Medical Ltd. | Electrical treatment of Parkinson's disease |
EP3765141A1 (en) | 2018-03-14 | 2021-01-20 | Rainbow Medical Ltd. | Electrical substance clearance from the brain |
US11123197B2 (en) | 2019-09-03 | 2021-09-21 | Rainbow Medical Ltd. | Hydropneumatic artificial intervertebral disc |
US10881858B1 (en) | 2019-09-18 | 2021-01-05 | Rainbow Medical Ltd. | Electrical substance clearance from the brain |
US11298530B1 (en) | 2021-05-03 | 2022-04-12 | Discure Technologies Ltd. | Synergistic therapies for intervertebral disc degeneration |
US11344721B1 (en) | 2021-08-16 | 2022-05-31 | Rainbow Medical Ltd. | Cartilage treatment |
US11413455B1 (en) | 2022-02-08 | 2022-08-16 | Rainbow Medical Ltd. | Electrical treatment of Alzheimer's disease |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0468636A1 (en) * | 1990-06-18 | 1992-01-29 | Boaz Avitall | Implantable iontophoretic delivery system |
US5647361A (en) * | 1992-09-28 | 1997-07-15 | Fonar Corporation | Magnetic resonance imaging method and apparatus for guiding invasive therapy |
US5893881A (en) * | 1995-09-08 | 1999-04-13 | Medtronic, Inc. | Method and apparatus for alleviating cardioversion shock pain by delivering a bolus of analgesic |
US5925066A (en) * | 1995-10-26 | 1999-07-20 | Galvani, Ltd. | Atrial arrythmia sensor with drug and electrical therapy control apparatus |
US5964705A (en) * | 1997-08-22 | 1999-10-12 | Image-Guided Drug Delivery System, Inc. | MR-compatible medical devices |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8403138D0 (en) | 1984-02-07 | 1984-03-14 | Graham N B | Sustained release of active ingredient |
US4824436A (en) | 1985-04-09 | 1989-04-25 | Harvey Wolinsky | Method for the prevention of restenosis |
US5017566A (en) | 1987-12-30 | 1991-05-21 | University Of Florida | Redox systems for brain-targeted drug delivery |
US5580575A (en) | 1989-12-22 | 1996-12-03 | Imarx Pharmaceutical Corp. | Therapeutic drug delivery systems |
US5171217A (en) | 1991-02-28 | 1992-12-15 | Indiana University Foundation | Method for delivery of smooth muscle cell inhibitors |
US5226902A (en) | 1991-07-30 | 1993-07-13 | University Of Utah | Pulsatile drug delivery device using stimuli sensitive hydrogel |
US5344402A (en) | 1993-06-30 | 1994-09-06 | Cardiovascular Dynamics, Inc. | Low profile perfusion catheter |
US5514092A (en) | 1994-08-08 | 1996-05-07 | Schneider (Usa) Inc. | Drug delivery and dilatation-drug delivery catheters in a rapid exchange configuration |
-
2001
- 2001-05-04 WO PCT/US2001/014524 patent/WO2001085027A2/en active Application Filing
- 2001-05-04 EP EP01931071A patent/EP1280456A2/en not_active Withdrawn
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0468636A1 (en) * | 1990-06-18 | 1992-01-29 | Boaz Avitall | Implantable iontophoretic delivery system |
US5647361A (en) * | 1992-09-28 | 1997-07-15 | Fonar Corporation | Magnetic resonance imaging method and apparatus for guiding invasive therapy |
US5893881A (en) * | 1995-09-08 | 1999-04-13 | Medtronic, Inc. | Method and apparatus for alleviating cardioversion shock pain by delivering a bolus of analgesic |
US5925066A (en) * | 1995-10-26 | 1999-07-20 | Galvani, Ltd. | Atrial arrythmia sensor with drug and electrical therapy control apparatus |
US5964705A (en) * | 1997-08-22 | 1999-10-12 | Image-Guided Drug Delivery System, Inc. | MR-compatible medical devices |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9125979B2 (en) | 2007-10-25 | 2015-09-08 | Proteus Digital Health, Inc. | Fluid transfer port information system |
US9008761B2 (en) | 2010-02-01 | 2015-04-14 | Proteus Digital Health, Inc. | Two-wrist data gathering system |
US9014779B2 (en) | 2010-02-01 | 2015-04-21 | Proteus Digital Health, Inc. | Data gathering system |
Also Published As
Publication number | Publication date |
---|---|
WO2001085027A2 (en) | 2001-11-15 |
EP1280456A2 (en) | 2003-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001085027A3 (en) | Drug deliver catheter device with active electrode | |
Aryal et al. | Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood–tumor and blood–brain barriers improve outcomes in a rat glioma model | |
US6514221B2 (en) | Blood-brain barrier opening | |
US9669198B2 (en) | System and method for intracranial implantation of therapeutic or diagnostic agents | |
JP3981415B2 (en) | Inflatable device for tumor therapy | |
CA2413798A1 (en) | Needle for intradermal delivery of substances having penetration limiting means | |
US8715240B2 (en) | Apparatus and method for convection enhanced therapeutic delivery | |
EP1835956A2 (en) | Introduction of agent with medical device | |
CN105377354A (en) | Apparatus, systems and methods for delivery of medication to the brain to treat neurological condidtions | |
EP1180380A3 (en) | Catheter apparatus for medical treatment | |
Thomale et al. | Local chemotherapy in the rat brainstem with multiple catheters: a feasibility study | |
Treat et al. | MRI-guided focused ultrasound-enhanced chemotherapy of 9L rat gliosarcoma: Survival study | |
Naidoo et al. | Convection-Enhanced Drug Delivery in the Central Nervous System | |
Hayashi et al. | Gamma Knife pituitary radiosurgery for thalamic pain syndrome: new treatment trial in our institutional experience | |
Liu et al. | Focused ultrasound induced blood‐brain barrier disruption to enhance chemotherapeutic drugs (BCNU) delivery for glioblastoma treatment | |
WO2020206244A1 (en) | Systems and methods for advancing a catheter to a target site | |
Edwards et al. | Hyperthermia treatment for malignant brain tumors: nursing management during therapy | |
Mortele et al. | Magnetic Resonance Imaging Guidance for Tumor Ablation | |
LAZORTHES et al. | Advances in Drug Delivery Systems and Applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001931071 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001931071 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |